Intercorrelation of Molecular Biomarkers and Clinical Phenotype Measures in Fragile X Syndrome

This study contributes to a greater understanding of the utility of molecular biomarkers to identify clinical phenotypes of fragile X syndrome (FXS). Correlations of baseline clinical trial data (molecular measures—FMR1 mRNA, CYFIP1 mRNA, MMP9 and FMRP protein expression levels, nonverbal IQ, body m...

Descripción completa

Detalles Bibliográficos
Autores principales: Aishworiya, Ramkumar, Chi, Mei-Hung, Zafarullah, Marwa, Mendoza, Guadalupe, Ponzini, Matthew Dominic, Kim, Kyoungmi, Biag, Hazel Maridith Barlahan, Thurman, Angela John, Abbeduto, Leonard, Hessl, David, Randol, Jamie Leah, Bolduc, Francois V., Jacquemont, Sebastien, Lippé, Sarah, Hagerman, Paul, Hagerman, Randi, Schneider, Andrea, Tassone, Flora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377864/
https://www.ncbi.nlm.nih.gov/pubmed/37508583
http://dx.doi.org/10.3390/cells12141920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377864/
https://www.ncbi.nlm.nih.gov/pubmed/37508583
http://dx.doi.org/10.3390/cells12141920

Ejemplares similares